Lineage Cell Therapeutics (LCTX) Goodwill & Intangibles (2010 - 2026)

Lineage Cell Therapeutics' Goodwill & Intangibles history runs 17 years deep, the most recent figure standing at $42.4 million for Q1 2026.

• On a quarterly basis, Goodwill & Intangibles rose 297.04% year-over-year to $42.4 million in Q1 2026; TTM through Mar 2026 was $42.4 million, a 297.04% increase from a year earlier, with the FY2025 full-year figure at $42.4 million, down 25.94% from the prior year.
• Goodwill & Intangibles steadied at $42.4 million in Q1 2026 per LCTX's latest filing, from $42.4 million in the prior quarter.
• Across five years, Goodwill & Intangibles topped out at $76.8 million in Q4 2022 and bottomed at $10.7 million in Q1 2025.
• The 5-year median for Goodwill & Intangibles is $57.2 million (2024), against an average of $56.0 million.
• Across the five-year window, Goodwill & Intangibles tumbled 86.11% in 2025 and soared 297.04% in 2026, its largest moves.
• Year by year, Goodwill & Intangibles stood at $76.8 million in 2022, then decreased by 25.49% to $57.2 million in 2023, then fell by 0.04% to $57.2 million in 2024, then retreated by 25.94% to $42.4 million in 2025, then changed by 0.0% to $42.4 million in 2026.
• Per Business Quant, the three latest LCTX Goodwill & Intangibles figures stand at $42.4 million (Q1 2026), $42.4 million (Q4 2025), and $42.4 million (Q3 2025).